BioMS Medical Corp (TSX: MS), a leading
developer of products for the treatment of multiple sclerosis (MS), is pleased
to announce the appointment of Mr. Bryan McKnight to the Company's Board of
Directors and Chair of the Audit Committee and Mr. Gordon Politeski as an
advisor to the Board pending his nomination as a Director at the Company's
next annual meeting of shareholders.
